Cancer immunotherapy efficacy is driven by tumour biology, not by its histology. Impact on drug development and approvals. (February 2022) - Bonvalet, Mélodie; Danlos, François-Xavier; Champiat, Stéphane; Rouanne, Mathieu; Marabelle, Aurélien